Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom (addendum)

NEXT STORY
Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress
PREV STORY
Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

author_avatar
NASDAQ Market News

Dawn Howard-Mistry, MSN, BSN, APN-C, is Elected to the American Health Council’s Board of Nurses

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud ...

author_avatar
NASDAQ Market News

INNATE PHARMA : Publication of monalizumab research in the prestigious “Cell” journal

Innate Pharma announces publication of monalizumab research in the prestigious "Cell" journal widening the ...

author_avatar
NASDAQ Market News